Abzu and Contera Pharma partner to design RNA therapeutics for rare diseases using xAI technology

The latest buzz about Abzu - Abzu news and press releases

According to recent research in European Journal of Human Genetics, there are more than 6.000 rare diseases affecting more than 300 million people world-wide. Today, only 450 FDA-approved orphan drug products are available, which leaves hundreds of millions suffering from chronic diseases and at risk of early death. Nucleic acid-based medicine (NABM), also known as RNA therapeutics, is […]